1. Home
  2. OSUR vs SNFCA Comparison

OSUR vs SNFCA Comparison

Compare OSUR & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • SNFCA
  • Stock Information
  • Founded
  • OSUR 2000
  • SNFCA 1965
  • Country
  • OSUR United States
  • SNFCA United States
  • Employees
  • OSUR N/A
  • SNFCA N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • SNFCA Finance: Consumer Services
  • Sector
  • OSUR Health Care
  • SNFCA Finance
  • Exchange
  • OSUR Nasdaq
  • SNFCA Nasdaq
  • Market Cap
  • OSUR 289.4M
  • SNFCA 285.8M
  • IPO Year
  • OSUR 1986
  • SNFCA N/A
  • Fundamental
  • Price
  • OSUR $3.91
  • SNFCA $12.83
  • Analyst Decision
  • OSUR Buy
  • SNFCA
  • Analyst Count
  • OSUR 3
  • SNFCA 0
  • Target Price
  • OSUR $6.67
  • SNFCA N/A
  • AVG Volume (30 Days)
  • OSUR 907.9K
  • SNFCA 57.0K
  • Earning Date
  • OSUR 11-06-2024
  • SNFCA 11-14-2024
  • Dividend Yield
  • OSUR N/A
  • SNFCA N/A
  • EPS Growth
  • OSUR N/A
  • SNFCA N/A
  • EPS
  • OSUR 0.15
  • SNFCA 1.23
  • Revenue
  • OSUR $224,263,000.00
  • SNFCA $330,162,091.00
  • Revenue This Year
  • OSUR N/A
  • SNFCA N/A
  • Revenue Next Year
  • OSUR N/A
  • SNFCA N/A
  • P/E Ratio
  • OSUR $25.98
  • SNFCA $10.64
  • Revenue Growth
  • OSUR N/A
  • SNFCA N/A
  • 52 Week Low
  • OSUR $3.72
  • SNFCA $6.19
  • 52 Week High
  • OSUR $8.45
  • SNFCA $13.59
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 47.69
  • SNFCA 65.11
  • Support Level
  • OSUR $3.78
  • SNFCA $12.50
  • Resistance Level
  • OSUR $4.18
  • SNFCA $13.29
  • Average True Range (ATR)
  • OSUR 0.16
  • SNFCA 0.41
  • MACD
  • OSUR 0.03
  • SNFCA -0.11
  • Stochastic Oscillator
  • OSUR 37.21
  • SNFCA 30.28

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: